Restricted accessCorrectionFirst published 2019-11-01pp. 797-797Corrigendum to “Impact of Regulatory Incentive Programs on the Future of Pediatric Drug Development”
Restricted accessEditorialFirst published 2019-11-01pp. 721-723The Problem With Current Proposals to Address High Medicare Part B Drug Prices Gregory W. Daniel
Restricted accessReview articleFirst published 2019-11-01pp. 781-786Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives Jobin JoseORCID, Naziya Refi Rafeek
Restricted accessResearch articleFirst published 2019-11-01pp. 752-758Clinical Development of Biologics Approved by the US Food and Drug Administration,2003-2016 G. Caleb Alexander, Ken Ogasawara, Dana Wiegand , [...]View all